Peter Geserick

2.7k total citations · 2 hit papers
21 papers, 2.1k citations indexed

About

Peter Geserick is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Peter Geserick has authored 21 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 9 papers in Immunology and 4 papers in Oncology. Recurrent topics in Peter Geserick's work include Cell death mechanisms and regulation (16 papers), RNA Interference and Gene Delivery (4 papers) and Cancer-related Molecular Pathways (4 papers). Peter Geserick is often cited by papers focused on Cell death mechanisms and regulation (16 papers), RNA Interference and Gene Delivery (4 papers) and Cancer-related Molecular Pathways (4 papers). Peter Geserick collaborates with scholars based in Germany, Australia and United Kingdom. Peter Geserick's co-authors include Martin Leverkus, Maria Feoktistova, Mike Hupe, Beate Kellert, Georg Häcker, Marion MacFarlane, Claudia Langlais, Kelvin Cain, Harald Gollnick and M. Leverkus and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Cell Biology and Molecular Cell.

In The Last Decade

Peter Geserick

19 papers receiving 2.1k citations

Hit Papers

cIAPs Block Ripoptosome Formation, a RIP1/Caspase-8 Conta... 2011 2026 2016 2021 2011 2016 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. cIAPs Block Ripoptosome Formation, a RIP1/Caspase-8 Containing Intracellular Cell Death Complex Differentially Regulated by cFLIP Isoforms
    2011 687 citations Maria Feoktistova, Peter Geserick et al. Molecular Cell profile →
  2. Crystal Violet Assay for Determining Viability of Cultured Cells
    2016 650 citations Maria Feoktistova, Peter Geserick et al. Cold Spring Harbor Protocols profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Geserick Germany 14 1.5k 721 350 306 271 21 2.1k
Maria Feoktistova Germany 16 1.9k 1.2× 915 1.3× 417 1.2× 364 1.2× 373 1.4× 25 2.6k
Sandrine Jouan-Lanhouet France 8 1.7k 1.1× 700 1.0× 426 1.2× 340 1.1× 389 1.4× 8 2.3k
Yves Dondelinger Belgium 16 2.1k 1.4× 1.2k 1.6× 472 1.3× 317 1.0× 407 1.5× 21 2.7k
Xiao‐Ming Gao China 29 1.1k 0.8× 896 1.2× 178 0.5× 182 0.6× 183 0.7× 111 2.7k
Xiao Yu China 22 1.9k 1.3× 665 0.9× 298 0.9× 608 2.0× 228 0.8× 57 3.0k
Yuanyuan Zheng China 17 1000 0.7× 683 0.9× 637 1.8× 317 1.0× 185 0.7× 40 1.9k
Maria Rosaria Ruocco Italy 25 886 0.6× 472 0.7× 330 0.9× 515 1.7× 163 0.6× 51 1.8k

Countries citing papers authored by Peter Geserick

Since Specialization
Citations

This map shows the geographic impact of Peter Geserick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Geserick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Geserick more than expected).

Fields of papers citing papers by Peter Geserick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Geserick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Geserick. The network helps show where Peter Geserick may publish in the future.

Co-authorship network of co-authors of Peter Geserick

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Geserick. A scholar is included among the top collaborators of Peter Geserick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Geserick. Peter Geserick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Bauer, Wolfgang, et al.. (2025). Pentraxin-3, MyD88, GLP-1, and PD-L1: Performance assessment and composite algorithmic analysis for sepsis identification. Journal of Infection. 91(3). 106599–106599.
3.
Ulke, Jannis, et al.. (2024). PTPRJ is a negative regulator of insulin signaling in neuronal cells, impacting protein biosynthesis, and neurite outgrowth. Journal of Neuroendocrinology. 36(12). e13446–e13446. 1 indexed citations
4.
Ulke, Jannis, et al.. (2023). High-fat diet alters N-glycosylation of PTPRJ in murine liver. The Journal of Nutritional Biochemistry. 123. 109500–109500. 4 indexed citations
5.
Feoktistova, Maria, Fredrik Wållberg, Tencho Tenev, et al.. (2016). Techniques to Distinguish Apoptosis from Necroptosis. Cold Spring Harbor Protocols. 2016(4). pdb.top070375–pdb.top070375. 13 indexed citations
6.
Feoktistova, Maria, Peter Geserick, & Martin Leverkus. (2016). Ripoptosome Analysis by Caspase-8 Coimmunoprecipitation. Cold Spring Harbor Protocols. 2016(3). pdb.prot087403–pdb.prot087403. 8 indexed citations
7.
Feoktistova, Maria, Peter Geserick, & Martin Leverkus. (2016). Crystal Violet Assay for Determining Viability of Cultured Cells. Cold Spring Harbor Protocols. 2016(4). pdb.prot087379–pdb.prot087379. 650 indexed citations breakdown →
8.
Geserick, Peter, Sebastian Horn, Philip A. Harris, et al.. (2015). Absence of RIPK3 predicts necroptosis resistance in malignant melanoma. Cell Death and Disease. 6(9). e1884–e1884. 127 indexed citations
9.
Geserick, Peter, et al.. (2014). Characterization of the Ripoptosome and Its Components. Methods in enzymology on CD-ROM/Methods in enzymology. 545. 83–102. 30 indexed citations
10.
Geserick, Peter, et al.. (2014). The ratio of Mcl-1 and Noxa determines ABT737 resistance in squamous cell carcinoma of the skin. Cell Death and Disease. 5(9). e1412–e1412. 28 indexed citations
11.
Panayotova‐Dimitrova, Diana, Maria Feoktistova, Beate Kellert, et al.. (2013). cFLIP Regulates Skin Homeostasis and Protects against TNF-Induced Keratinocyte Apoptosis. Cell Reports. 5(2). 397–408. 61 indexed citations
12.
Geserick, Peter, et al.. (2012). Cell Death in the Skin: How to Study Its Quality and Quantity?. Methods in molecular biology. 961. 201–218. 10 indexed citations
13.
Feoktistova, Maria, Peter Geserick, Diana Panayotova‐Dimitrova, & Martin Leverkus. (2012). Pick your poison: The Ripoptosome, a cell death platform regulating apoptosis and necroptosis. Cell Cycle. 11(3). 460–467. 57 indexed citations
14.
Kavuri, Shyam M., Peter Geserick, Daniela Berg, et al.. (2011). Cellular FLICE-inhibitory Protein (cFLIP) Isoforms Block CD95- and TRAIL Death Receptor-induced Gene Induction Irrespective of Processing of Caspase-8 or cFLIP in the Death-inducing Signaling Complex. Journal of Biological Chemistry. 286(19). 16631–16646. 72 indexed citations
15.
Feoktistova, Maria, Peter Geserick, Beate Kellert, et al.. (2011). cIAPs Block Ripoptosome Formation, a RIP1/Caspase-8 Containing Intracellular Cell Death Complex Differentially Regulated by cFLIP Isoforms. Molecular Cell. 43(3). 449–463. 687 indexed citations breakdown →
16.
Schmidt, Marc, Mike Hupe, Badrinarayanan Raghavan, et al.. (2009). The contact allergen nickel sensitizes primary human endothelial cells and keratinocytes to TRAIL‐mediated apoptosis. Journal of Cellular and Molecular Medicine. 14(6b). 1760–1776. 19 indexed citations
17.
Geserick, Peter, Mike Hupe, Maryline Moulin, et al.. (2009). Cellular IAPs inhibit a cryptic CD95-induced cell death by limiting RIP1 kinase recruitment. The Journal of Cell Biology. 187(7). 1037–1054. 198 indexed citations
18.
Leverkus, Martin, et al.. (2008). FLIP ing the coin? Death receptor‐mediated signals during skin tumorigenesis. Experimental Dermatology. 17(7). 614–622. 17 indexed citations
19.
Hupe, Mike, Martin R. Sprick, Andreas Kerstan, et al.. (2007). NF-κB Inhibition Reveals Differential Mechanisms of TNF Versus TRAIL-Induced Apoptosis Upstream or at the Level of Caspase-8 Activation Independent of cIAP2. Journal of Investigative Dermatology. 128(5). 1134–1147. 59 indexed citations
20.
Geserick, Peter, Claudia Drewniok, Mike Hupe, et al.. (2007). Suppression of cFLIP is sufficient to sensitize human melanoma cells to TRAIL- and CD95L-mediated apoptosis. Oncogene. 27(22). 3211–3220. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria Feoktistova Breakdown of academic impact, for papers by Sandrine Jouan-Lanhouet Breakdown of academic impact, for papers by Yves Dondelinger Breakdown of academic impact, for papers by Xiao‐Ming Gao Breakdown of academic impact, for papers by Xiao Yu Breakdown of academic impact, for papers by Yuanyuan Zheng Breakdown of academic impact, for papers by Maria Rosaria Ruocco
Rankless by CCL
2026